Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us

Profile

Baik-Lin Seong

BS

Baik-Lin Seong

Yonsei University, Republic of Korea

Baik-Lin Seong, PhD, is Professor of Yonsei University College of Medicine, and Director General of Vaccine Innovative Technology ALliance (VITAL)-Korea. He served as a member of the Presidential Advisory Council of Science & Technology of Korean Government (2021-2022) and the Scientific Advisory Board of International Vaccine Institute (IVI) (2018-2022). He was the chair of the COVID-19 Vaccine Pan-Government Strategic Plan of Korean Government. With a view to ensure equitable access of effective vaccines to LMICs, he works on developing a low-cost bacterial production of VLP/nanoparticle vaccines against RSV, norovirus, highly pathogenic avian influenza, and flaviviruses including Japanese Encephalitis, Zika, and West Nile viruses